CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · General Reference

Mescaloruvic acid

pharmaceutical compound

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionJun 27, 2026
Entity authorityQ140332760 ↗
Source-derived summary

Mescaloruvic acid, also known as N-(1-carboxyethyl)mescaline or as N-(1-carboxyethyl)-3,4,5-trimethoxyphenethylamine, is an alkaloid of the phenethylamine and scaline families related to the psychedelic drug mescaline. It is the N-(1-carboxyethyl) derivative of mescaline. The alkaloid has been reported to be a trace constituent of peyote (Lophophora williamsii), though findings appear conflicting. It was first described in the scientific literature by 1972.

Editorial summary

The public source identifies “Mescaloruvic acid” as pharmaceutical compound. This brief keeps that definition visible, then builds a research path around Mescaloruvic, acid and pharmaceutical.

Editorial reviewA dependable orientation record for establishing vocabulary, names and a first evidence trail. The current lead gives the account dated anchors—1972—that can be checked directly. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with Mescaloruvic, acid and pharmaceutical providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “Mescaloruvic acid”, the useful work is to connect “pharmaceutical compound” to the records capable of establishing context and consequence.

Evidence profile

Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Jun 27, 2026. The linked authority identifier is Q140332760. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1972.

Critical limits

Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Mescaloruvic acid”, its source revision and the description used here.
  2. Expand the search: follow Mescaloruvic acid primary sources, Mescaloruvic acid archive and Mescaloruvic research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Mescaloruvic acid”?
  2. Which cited source is closest to the event, object or claim?
  3. Which institution is responsible for the underlying evidence?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Mescaloruvic acid” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.